Diagnostic and Therapeutic Strategy Updates of Rare Oncogenic Mutations in Chinese Society of Clinical Oncology Guidelines on Diagnosis and Treatment of Non-small Cell Lung Cancer (2023 Edition)

Diagnostic and Therapeutic Strategy Updates of Rare Oncogenic Mutations in Chinese Society of Clinical Oncology Guidelines on Diagnosis and Treatment of Non-small Cell Lung Cancer (2023 Edition)

The Chinese Society of Clinical Oncology (CSCO) issued the new version of the guidelines on diagnosis and treatment of NSCLC in April 2023.The new version updated the diagnostic and therapeutic strategy of rare oncogenic mutations, including ROS1 fusion, BRAF V600E mutation, NTRK fusion, MET exon 14...

Full description

Bibliographic Details
Main Authors: LI Yingge, DONG Yi, YU Shuyang, WEN Yingmei, SONG Qibin, YAO Yi
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-12-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
nsclc
rare oncogenic mutations
diagnosis and therapy
guidelines updates
csco
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.1022

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.1022

Similar Items